Coya Therapeutics, Inc. Common Stock Financial Flexibility Index
Coya Therapeutics, Inc. Common Stock financial flexibility index. Coya Therapeutics, Inc. Common Stock (COYA) has a Financial Flexibility Index of -3.39x as of June 2026. Free cash flow of $-13.67 Billion (operating CF $-13.67 Billion minus capex $885.00K) represents -3% of total liabilities ($4.03 Billion). See Coya Therapeutics, Inc. Common Stock free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Coya Therapeutics, Inc. Common Stock (2020–2025)
Financial flexibility index of Coya Therapeutics, Inc. Common Stock from 2020 to 2025. Historical Financial Flexibility Index trend for Coya Therapeutics, Inc. Common Stock across 6 annual periods. Check cash flow quality index of Coya Therapeutics, Inc. Common Stock to evaluate the quality of earnings relative to operating cash generation.
Coya Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2020–2025)
Coya Therapeutics, Inc. Common Stock financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Coya Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see how efficiently does Coya Therapeutics, Inc. Common Stock generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.55x | $-10.74 Million | $-10.74 Million | $6.92 Million | ▲ +28.1% |
| 2024 | -2.16x | $-10.29 Million | $-10.29 Million | $4.77 Million | ▼ -8.5% |
| 2023 | -1.99x | $-11.19 Million | $-11.19 Million | $5.63 Million | ▼ -361.2% |
| 2022 | -0.43x | $-7.24 Million | $-7.24 Million | $16.79 Million | ▲ +86.9% |
| 2021 | -3.28x | $-3.77 Million | $-3.90 Million | $1.15 Million | ▼ -274.8% |
| 2020 | -0.88x | $-391.26K | $-391.27K | $447.12K | — |